Ypsomed Holding
SWX:YPSN Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
WA
Consensus Narrative from 5 Analysts
GLP-1 Partnerships And Capacity Expansion To Drive Revenue Growth And Boost Margins
Key Takeaways Ypsomed's shift to a B2B model and local manufacturing may streamline operations, improve focus, and reduce geopolitical risks, enhancing margins and earnings. Expansion in manufacturing capacity and a robust project pipeline positions Ypsomed for long-term revenue growth in self-injection and drug delivery systems.
View narrativeCHF 415.60
FV
12.9% undervalued intrinsic discount18.71%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
23 days ago author updated this narrative